Bangladesh
· Delayed Price · Currency is BDT Orion Infusion Statistics
Total Valuation
Orion Infusion has a market cap or net worth of BDT 7.71 billion. The enterprise value is 7.98 billion.
| Market Cap | 7.71B |
| Enterprise Value | 7.98B |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Orion Infusion has 20.36 million shares outstanding.
| Shares Outstanding | 20.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 18.85% |
| Owned by Institutions (%) | n/a |
| Float | 12.09M |
Valuation Ratios
The trailing PE ratio is 180.45.
| PE Ratio | 180.45 |
| Forward PE | n/a |
| PS Ratio | 9.06 |
| PB Ratio | 25.37 |
| P/FCF Ratio | 198.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 76.94, with an EV/FCF ratio of 205.12.
| EV / Earnings | 186.85 |
| EV / Sales | 9.38 |
| EV / EBITDA | 76.94 |
| EV / EBIT | 96.53 |
| EV / FCF | 205.12 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 98.16.
| Current Ratio | 0.86 |
| Quick Ratio | 0.26 |
| Debt / Equity | 98.16 |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 7.66 |
| Interest Coverage | 2.70 |
Financial Efficiency
Return on equity (ROE) is 14.62% and return on invested capital (ROIC) is 8.52%.
| Return on Equity (ROE) | 14.62% |
| Return on Assets (ROA) | 6.57% |
| Return on Capital (ROIC) | 8.52% |
| Revenue Per Employee | 1.11M |
| Profits Per Employee | 55,896 |
| Employee Count | 764 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 3.94 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.55% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +17.55% |
| 50-Day Moving Average | 448.53 |
| 200-Day Moving Average | 488.04 |
| Relative Strength Index (RSI) | 49.32 |
| Average Volume (20 Days) | 126,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Orion Infusion had revenue of BDT 850.39 million and earned 42.70 million in profits. Earnings per share was 2.10.
| Revenue | 850.39M |
| Gross Profit | 341.87M |
| Operating Income | 82.66M |
| Pretax Income | 51.26M |
| Net Income | 42.70M |
| EBITDA | 95.08M |
| EBIT | 82.66M |
| Earnings Per Share (EPS) | 2.10 |
Balance Sheet
The company has 19.24 million in cash and 298.12 million in debt, giving a net cash position of -272.99 million or -13.41 per share.
| Cash & Cash Equivalents | 19.24M |
| Total Debt | 298.12M |
| Net Cash | -272.99M |
| Net Cash Per Share | -13.41 |
| Equity (Book Value) | 303.72M |
| Book Value Per Share | 14.92 |
| Working Capital | -64.72M |
Cash Flow
In the last 12 months, operating cash flow was 113.36 million and capital expenditures -74.46 million, giving a free cash flow of 38.90 million.
| Operating Cash Flow | 113.36M |
| Capital Expenditures | -74.46M |
| Free Cash Flow | 38.90M |
| FCF Per Share | 1.91 |
Margins
Gross margin is 40.20%, with operating and profit margins of 9.72% and 5.02%.
| Gross Margin | 40.20% |
| Operating Margin | 9.72% |
| Pretax Margin | 6.03% |
| Profit Margin | 5.02% |
| EBITDA Margin | 11.18% |
| EBIT Margin | 9.72% |
| FCF Margin | 4.57% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.26%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.26% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 26.04% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.26% |
| Earnings Yield | 0.55% |
| FCF Yield | 0.50% |
Stock Splits
The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.
| Last Split Date | Dec 4, 2011 |
| Split Type | Forward |
| Split Ratio | 10 |